FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

32760711000001102: Daratumumab (substance)


    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2016. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    99912701000001113 Daratumumab (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    99912801000001116 Daratumumab en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Daratumumab Is a Monoclonal antibody agent false Inferred relationship Existential restriction modifier

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Daratumumab 100mg/5ml solution for infusion vials Has specific active ingredient False Daratumumab Inferred relationship Existential restriction modifier
    Daratumumab 400mg/20ml solution for infusion vials Has specific active ingredient False Daratumumab Inferred relationship Existential restriction modifier
    Darzalex 100mg/5ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) Has specific active ingredient False Daratumumab Inferred relationship Existential restriction modifier
    Darzalex 400mg/20ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) Has specific active ingredient False Daratumumab Inferred relationship Existential restriction modifier
    Daratumumab 400mg/20ml solution for infusion vials 1 vial Has specific active ingredient False Daratumumab Inferred relationship Existential restriction modifier
    Daratumumab 100mg/5ml solution for infusion vials 1 vial Has specific active ingredient False Daratumumab Inferred relationship Existential restriction modifier
    Darzalex 100mg/5ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) 1 vial Has specific active ingredient False Daratumumab Inferred relationship Existential restriction modifier
    Darzalex 400mg/20ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) 1 vial Has specific active ingredient False Daratumumab Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start